Status: Available
Expanded Access to Zofin for Patients With COVID-19
This expanded access protocol will provide access to the investigational product Zofin for patients in outpatient facilities infected with SARS-CoV-2 who have mild to moderate COVID-19, or who are judged by a healthcare provider to be at high risk of progression to moderate disease.
Trial details
Age: 18+Biological sex: AllType: Expanded AccessSponsor: ZEO ScientifiX, Inc.Updated: Mar 23, 2023
Eligibility criteria
Provide written informed consent [+30]
Patients who have moderate to severe respiratory distress syndrome due to COVID-... [+6]